Amica Mutual Insurance Co. Has $698,000 Stake in Waters Corporation (WAT)
Amica Mutual Insurance Co. lessened its holdings in shares of Waters Corporation (NYSE:WAT) by 48.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,890 shares of the medical instruments supplier’s stock after selling 3,625 shares during the period. Amica Mutual Insurance Co.’s holdings in Waters Corporation were worth $698,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Robecosam AG raised its stake in Waters Corporation by 43.8% in the 3rd quarter. Robecosam AG now owns 287,789 shares of the medical instruments supplier’s stock worth $51,451,000 after acquiring an additional 87,616 shares during the last quarter. Davidson Investment Advisors raised its stake in Waters Corporation by 44.9% in the 3rd quarter. Davidson Investment Advisors now owns 38,581 shares of the medical instruments supplier’s stock worth $6,926,000 after acquiring an additional 11,955 shares during the last quarter. Norinchukin Bank The raised its stake in Waters Corporation by 7.0% in the 3rd quarter. Norinchukin Bank The now owns 5,942 shares of the medical instruments supplier’s stock worth $1,067,000 after acquiring an additional 387 shares during the last quarter. D.A. Davidson & CO. raised its stake in Waters Corporation by 5.6% in the 3rd quarter. D.A. Davidson & CO. now owns 12,699 shares of the medical instruments supplier’s stock worth $2,279,000 after acquiring an additional 669 shares during the last quarter. Finally, Mawer Investment Management Ltd. raised its stake in Waters Corporation by 2.3% in the 3rd quarter. Mawer Investment Management Ltd. now owns 416,664 shares of the medical instruments supplier’s stock worth $74,800,000 after acquiring an additional 9,173 shares during the last quarter. Hedge funds and other institutional investors own 92.04% of the company’s stock.
In other news, Director Thomas P. Salice sold 3,500 shares of the firm’s stock in a transaction dated Monday, November 20th. The stock was sold at an average price of $200.03, for a total transaction of $700,105.00. Following the sale, the director now directly owns 20,349 shares in the company, valued at approximately $4,070,410.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Elizabeth B. Rae sold 12,000 shares of the firm’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $197.95, for a total value of $2,375,400.00. Following the sale, the senior vice president now owns 18,129 shares in the company, valued at $3,588,635.55. The disclosure for this sale can be found here. Insiders have sold a total of 60,813 shares of company stock worth $11,820,747 over the last 90 days. Insiders own 5.07% of the company’s stock.
Shares of Waters Corporation (WAT) traded down $0.62 on Friday, reaching $195.95. The company’s stock had a trading volume of 153,380 shares, compared to its average volume of 382,968. The firm has a market cap of $15,633.81, a P/E ratio of 27.30, a P/E/G ratio of 2.85 and a beta of 0.83. The company has a debt-to-equity ratio of 0.66, a current ratio of 6.16 and a quick ratio of 5.71. Waters Corporation has a 12 month low of $133.35 and a 12 month high of $200.71.
Waters Corporation (NYSE:WAT) last announced its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.03. The company had revenue of $565.58 million for the quarter, compared to the consensus estimate of $555.25 million. Waters Corporation had a return on equity of 23.61% and a net margin of 24.34%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the firm earned $1.57 EPS. analysts predict that Waters Corporation will post 7.42 earnings per share for the current fiscal year.
WAT has been the subject of a number of research analyst reports. Deutsche Bank AG raised their target price on Waters Corporation from $199.00 to $200.00 and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $211.00 price target on the stock in a research report on Monday, October 23rd. Barclays PLC increased their price target on Waters Corporation from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 25th. Bank of America Corporation increased their price target on Waters Corporation from $192.00 to $202.00 and gave the stock a “neutral” rating in a research report on Friday, November 10th. Finally, Cowen Inc reaffirmed a “hold” rating and set a $190.00 price target on shares of Waters Corporation in a research report on Friday, November 3rd. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $193.62.
Waters Corporation Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.